Navigation Links
Ferring Pharmaceuticals' FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
Date:8/16/2010

PARSIPPANY, N.J., Aug. 16 /PRNewswire/ -- Ferring Pharmaceuticals Inc., the makers of FIRMAGON® (degarelix for injection), is in the race to end prostate cancer as an official sponsor of the Great Prostate Cancer Challenge / Dash for Dad, the premier prostate cancer race series in the United States, led by ZERO – The Project to End Prostate Cancer.  FIRMAGON® is a hormone antagonist therapy for advanced prostate cancer.

"ZERO's Dash for Dad exemplifies the determination needed to beat prostate cancer," said William Garbarini, Vice President, US Marketing, Ferring Pharmaceuticals Inc. "It is inspiring to see athletes, doctors and friends—but especially survivors and family members—race with such commitment to stop prostate cancer in its tracks. We are proud to support their efforts."  

This year, ZERO expects more than 7,000 participants across 14 cities in the Great Prostate Cancer Challenge / Dash for Dad.  Baltimore, Nashville, and Indianapolis are just a few of the cities where running races and walks will be held.  The widespread exposure generated by the events will go a long way toward advancing the organization's mission—zero tolerance for prostate cancer.

The first Dash for Dad race took place in 2008 in an effort to promote prostate cancer awareness, early detection and research. To date, the national series has raised more than one million dollars.  ZERO – The Project to End Prostate Cancer, dedicates the proceeds from each event to free prostate cancer screenings in the host community.

"We are thrilled Ferring has joined our race to end prostate cancer," said ZERO's CEO Skip Lockwood.  "Their product FIRMAGON is an important treatment option for advanced prostate cancer patients, and reflects their determination to help provide effective treatment for patients suffering with this disease. Teaming up
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ferring Pharmaceuticals FIRMAGON® Named Official Sponsor of Ed Randalls Bat for the Cure
2. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
3. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
4. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
5. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
6. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
7. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
8. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
9. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 2015 Research and Markets ... of the "Lab Accessories Market by ... Station) & End User (OEM/Biotechnology & Pharmaceutical ... 2020" report to their offering. ... expected to reach $504.7 million by 2020 ...
(Date:4/24/2015)... Company, Inc. (NYSE: LCI ) today announced that ... facility to $120 million from $50 million.  The amended ... company to increase borrowings by a total of up ... commitments from existing lenders or new lending institutions.  The ... 2018.   "The amended credit facility, together ...
(Date:4/23/2015)... CHICAGO, Ill. , April 24, 2015  AbbVie ... Food and Drug Administration (FDA) has accepted its New ... company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, ... for the treatment of adults with chronic genotype 4 ... regimen is the first all-oral, interferon-free therapy being evaluated ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
(Date:4/25/2015)... 2015 Carinsurancequotesinfo.com has released a new ... cost auto insurance for flatbed trucks. , ... sometimes other vehicles. They are mainly used for commercial ... released blog post explains that by comparing multiple offers, ... and other commercial vehicles. , It is now possible ...
(Date:4/25/2015)... Islands, BWI (PRWEB) April 25, 2015 ... has celebrated three months of successfully welcoming visitors to ... 5, 2015. , As part of a major ... Providenciales airport was completely redesigned to speed up arrivals. ... the process of getting out of the airport and ...
(Date:4/25/2015)... York New York (PRWEB) April 25, 2015 ... that Dr. Jerry Blaivas has been chosen by the New ... for his contributions to medicine in the field of Urology. ... the best in his speciality, Genito-Urinary diseases. He was ... specifically in the field of urology. Not only did ...
(Date:4/25/2015)... 2015 For thirteen years, the Twin Cities ... education event in the nation! This year, on May 5th, ... US to take DI Day on the road by supporting ... CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura ... on the change by stating, "The first Twin Cities DI ...
(Date:4/24/2015)... 24, 2015 Multi Customer Discount , ... pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's ... program. This does not include any Dig fees, or ... per person. If someone is part of this group ... totaling approximately 2500 gallons or more, the cost would ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3
... Qiao Xing,Mobile Communication Co., Ltd. (,Qiao Xing Mobile, or ... domestic manufacturers of mobile,handsets through its subsidiary CEC Telecom ... C7000A cardiograph mobile handset., The C7000A has ... will be able to perform a basic ...
... form of breast cancer are being tested in a ... six continents -- a clinical trial that investigators hope ... This trial, dubbed ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment ... initiatives in which two large, academic breast cancer research ...
... affected by ... rare diseases, NEW YORK, Feb. ... Day will be launched on Friday 29,February...because it,s a rare day that ... Shire plc at:, http://media.medialink.com/WebNR.aspx?story=34701 ), Collectively, rare diseases aren,t ...
... Firm,s Growing Healthcare Practice, BROOKFIELD, Wis., Feb. ... human resources outsourcing company, has added,Gordon Warner to ... Services,Director., Warner brings extensive HR experience and ... Warner comes to Pinstripe from,M&I Bank in Milwaukee, ...
... 28 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ... 2008 Susquehanna Healthcare Conference will be webcast ... Investors section of the Company,s website, http://www.millennium.com ... The presentation will include an overview ...
... Idaho, Feb. 28 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... groups across the United States, today announced,that Ernest G. ... of the,company,s Board of Directors for personal reasons. Mr. ... company intends to immediately begin a search,to identify a ...
Cached Medicine News:Health News:Qiao Xing Mobile's CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0'' LCD Screen 2Health News:Qiao Xing Mobile's CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0'' LCD Screen 3Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 2Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 3Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 4Health News:VIDEO from Medialink and Shire plc: Rare Diseases Must Be Top of the Health Agenda 2Health News:VIDEO from Medialink and Shire plc: Rare Diseases Must Be Top of the Health Agenda 3Health News:Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director 2Health News:2008 Susquehanna Healthcare Conference to Webcast Millennium Presentation 2Health News:NightHawk Radiology Holdings, Inc. Announces Board Member Departure 2
Indications For Usage: , Airway management during surgical procedures. , Long-term ventilatory management. ...
Indications For Usage: , Oral Surgery. , Maxillofacial surgery. ...
The Cuffed Endoflex endotracheal tube had a murphy eye, high volume, low pressure cuff., ,Endoflex endotracheal tubes are individual packaged in sterilized pouches, 10 units per box, 10 boxes pe...
... in-line, battery-powered disposable, lightweight and completely portable ... of intravenous application and irrigation warming. ... help prevent fluid-induced hypothermia. The Thermal ... (100.4°F) 3°C at a flow rate of ...
Medicine Products: